CD44 and breast cancer: In the case of breast cancer stem cells (BCSCs), Al-Hajj and colleagues prospectively isolated a tumorigenic population of cells from primary human breast cancer using FACs based on the ESA+/CD44+/CD24−/low/lineage− phenotype [191,193].